SEC Info℠  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Eli Lilly & Co. – ‘8-K’ for 3/17/23 – ‘XML’

On:  Friday, 3/17/23, at 4:05pm ET   ·   For:  3/17/23   ·   Accession #:  59478-23-118   ·   File #:  1-06351

Previous ‘8-K’:  ‘8-K’ on 2/24/23 for 2/23/23   ·   Next:  ‘8-K’ on / for 4/27/23   ·   Latest:  ‘8-K’ on 2/9/24 for 2/7/24   ·   2 References:   

Find Words in Filings emoji
 		  in    Show  and   ↓Hints

  As Of               Filer                 Filing    For·On·As Docs:Size

 3/17/23  Eli Lilly & Co.                   8-K:5       3/17/23   11:267K

Current Report   —   Form 8-K

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 8-K         Current Report                                      HTML     50K 
 6: R1          Cover Page                                          HTML     72K 
 9: XML         IDEA XML File -- Filing Summary                      XML     11K 
 7: XML         XBRL Instance -- lly-20230317_htm                    XML     41K 
 8: EXCEL       IDEA Workbook of Financial Reports                  XLSX      9K 
 3: EX-101.DEF  XBRL Definitions -- lly-20230317_def                 XML     49K 
 4: EX-101.LAB  XBRL Labels -- lly-20230317_lab                      XML    114K 
 5: EX-101.PRE  XBRL Presentations -- lly-20230317_pre               XML     51K 
 2: EX-101.SCH  XBRL Schema -- lly-20230317                          XSD     17K 
10: JSON        XBRL Instance as JSON Data -- MetaLinks               17±    23K 
11: ZIP         XBRL Zipped Folder -- 0000059478-23-000118-xbrl      Zip     22K

‘XML’   —   XBRL Instance — lly-20230317_htm

This Document is an XBRL XML File.

                                                                                                                                                                                
<?xml version="1.0" encoding="windows-1252"?>
<xbrl xml:lang="en-US" xmlns="http://www.xbrl.org/2003/instance" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:lly="http://www.lilly.com/20230317" xmlns:us-gaap="http://fasb.org/us-gaap/2022" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xlink="http://www.w3.org/1999/xlink">
<link:schemaRef xlink:href="lly-20230317.xsd" xlink:type="simple"/>
<context id="i55b5a9349f3c4011865eeedb73223072_D20230317-20230317">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000059478 </identifier>
</entity>
<period>
<startDate> 2023-03-17 </startDate>
<endDate> 2023-03-17 </endDate>
</period>
</context>
<context id="id15c08f8ea2c4ee2bcafaaa6d45dbe3f_D20230317-20230317">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000059478 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis"> us-gaap:CommonClassAMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2023-03-17 </startDate>
<endDate> 2023-03-17 </endDate>
</period>
</context>
<context id="i479ec16dc94145148bf3196b49ec4579_D20230317-20230317">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000059478 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis"> lly:A718NotesDueJune12025Member </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2023-03-17 </startDate>
<endDate> 2023-03-17 </endDate>
</period>
</context>
<context id="ica8d3824d21849b7a7da64565cd160a0_D20230317-20230317">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000059478 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis"> lly:A1.625NotesDueJune22026Member </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2023-03-17 </startDate>
<endDate> 2023-03-17 </endDate>
</period>
</context>
<context id="ia80236c4a4274bfa9aaa2a663c63be01_D20230317-20230317">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000059478 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis"> lly:A2.125NotesDueJune32030Member </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2023-03-17 </startDate>
<endDate> 2023-03-17 </endDate>
</period>
</context>
<context id="ibbd5c1346d1440fbad3d3b779ac7feda_D20230317-20230317">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000059478 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis"> lly:A625Notesdue2031Member </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2023-03-17 </startDate>
<endDate> 2023-03-17 </endDate>
</period>
</context>
<context id="ic2fbce5421e84b72b5ca953903f1a50b_D20230317-20230317">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000059478 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis"> lly:A500NotesDue2033Member </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2023-03-17 </startDate>
<endDate> 2023-03-17 </endDate>
</period>
</context>
<context id="if1e319d2317a4561a5dff80511807f9f_D20230317-20230317">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000059478 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis"> lly:A6.77NotesDueJanuary12036Member </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2023-03-17 </startDate>
<endDate> 2023-03-17 </endDate>
</period>
</context>
<context id="i2c5a13aca2324fe48e9a35d33e2f999e_D20230317-20230317">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000059478 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis"> lly:A1625NotesDue2043Member </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2023-03-17 </startDate>
<endDate> 2023-03-17 </endDate>
</period>
</context>
<context id="i6d19e4b8bdf047978a1b6f8bf80515c8_D20230317-20230317">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000059478 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis"> lly:A1.700Notesdue2049Member </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2023-03-17 </startDate>
<endDate> 2023-03-17 </endDate>
</period>
</context>
<context id="idc48241e1e47492f8216126fab19a77a_D20230317-20230317">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000059478 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis"> lly:A1125NotesDue2051Member </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2023-03-17 </startDate>
<endDate> 2023-03-17 </endDate>
</period>
</context>
<context id="id04ee066e89940ed95215795392babff_D20230317-20230317">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000059478 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis"> lly:A1375NotesDue2061Member </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2023-03-17 </startDate>
<endDate> 2023-03-17 </endDate>
</period>
</context>
<dei:EntityCentralIndexKey contextRef="i55b5a9349f3c4011865eeedb73223072_D20230317-20230317" id="f-51"> 0000059478 </dei:EntityCentralIndexKey>
<dei:AmendmentFlag contextRef="i55b5a9349f3c4011865eeedb73223072_D20230317-20230317" id="f-52"> false </dei:AmendmentFlag>
<dei:DocumentType contextRef="i55b5a9349f3c4011865eeedb73223072_D20230317-20230317" id="f-1"> 8-K </dei:DocumentType>
<dei:DocumentPeriodEndDate contextRef="i55b5a9349f3c4011865eeedb73223072_D20230317-20230317" id="f-2"> 2023-03-17 </dei:DocumentPeriodEndDate>
<dei:EntityRegistrantName contextRef="i55b5a9349f3c4011865eeedb73223072_D20230317-20230317" id="f-3"> ELI LILLY AND COMPANY </dei:EntityRegistrantName>
<dei:EntityIncorporationStateCountryCode contextRef="i55b5a9349f3c4011865eeedb73223072_D20230317-20230317" id="f-4"> IN </dei:EntityIncorporationStateCountryCode>
<dei:EntityFileNumber contextRef="i55b5a9349f3c4011865eeedb73223072_D20230317-20230317" id="f-5"> 001-06351 </dei:EntityFileNumber>
<dei:EntityTaxIdentificationNumber contextRef="i55b5a9349f3c4011865eeedb73223072_D20230317-20230317" id="f-6"> 35-0470950 </dei:EntityTaxIdentificationNumber>
<dei:EntityAddressAddressLine1 contextRef="i55b5a9349f3c4011865eeedb73223072_D20230317-20230317" id="f-7"> Lilly Corporate Center </dei:EntityAddressAddressLine1>
<dei:EntityAddressCityOrTown contextRef="i55b5a9349f3c4011865eeedb73223072_D20230317-20230317" id="f-8"> Indianapolis, </dei:EntityAddressCityOrTown>
<dei:EntityAddressStateOrProvince contextRef="i55b5a9349f3c4011865eeedb73223072_D20230317-20230317" id="f-9"> IN </dei:EntityAddressStateOrProvince>
<dei:EntityAddressPostalZipCode contextRef="i55b5a9349f3c4011865eeedb73223072_D20230317-20230317" id="f-10"> 46285 </dei:EntityAddressPostalZipCode>
<dei:CityAreaCode contextRef="i55b5a9349f3c4011865eeedb73223072_D20230317-20230317" id="f-11"> 317 </dei:CityAreaCode>
<dei:LocalPhoneNumber contextRef="i55b5a9349f3c4011865eeedb73223072_D20230317-20230317" id="f-12"> 276-2000 </dei:LocalPhoneNumber>
<dei:WrittenCommunications contextRef="i55b5a9349f3c4011865eeedb73223072_D20230317-20230317" id="f-13"> false </dei:WrittenCommunications>
<dei:SolicitingMaterial contextRef="i55b5a9349f3c4011865eeedb73223072_D20230317-20230317" id="f-14"> false </dei:SolicitingMaterial>
<dei:PreCommencementTenderOffer contextRef="i55b5a9349f3c4011865eeedb73223072_D20230317-20230317" id="f-15"> false </dei:PreCommencementTenderOffer>
<dei:PreCommencementIssuerTenderOffer contextRef="i55b5a9349f3c4011865eeedb73223072_D20230317-20230317" id="f-16"> false </dei:PreCommencementIssuerTenderOffer>
<dei:Security12bTitle contextRef="id15c08f8ea2c4ee2bcafaaa6d45dbe3f_D20230317-20230317" id="f-17"> Common Stock (no par value) </dei:Security12bTitle>
<dei:TradingSymbol contextRef="id15c08f8ea2c4ee2bcafaaa6d45dbe3f_D20230317-20230317" id="f-18"> LLY </dei:TradingSymbol>
<dei:SecurityExchangeName contextRef="id15c08f8ea2c4ee2bcafaaa6d45dbe3f_D20230317-20230317" id="f-19"> NYSE </dei:SecurityExchangeName>
<dei:Security12bTitle contextRef="i479ec16dc94145148bf3196b49ec4579_D20230317-20230317" id="f-20"> 7 1/8% Notes due 2025 </dei:Security12bTitle>
<dei:TradingSymbol contextRef="i479ec16dc94145148bf3196b49ec4579_D20230317-20230317" id="f-21"> LLY25 </dei:TradingSymbol>
<dei:SecurityExchangeName contextRef="i479ec16dc94145148bf3196b49ec4579_D20230317-20230317" id="f-22"> NYSE </dei:SecurityExchangeName>
<dei:Security12bTitle contextRef="ica8d3824d21849b7a7da64565cd160a0_D20230317-20230317" id="f-23"> 1.625% Notes due 2026 </dei:Security12bTitle>
<dei:TradingSymbol contextRef="ica8d3824d21849b7a7da64565cd160a0_D20230317-20230317" id="f-24"> LLY26 </dei:TradingSymbol>
<dei:SecurityExchangeName contextRef="ica8d3824d21849b7a7da64565cd160a0_D20230317-20230317" id="f-25"> NYSE </dei:SecurityExchangeName>
<dei:Security12bTitle contextRef="ia80236c4a4274bfa9aaa2a663c63be01_D20230317-20230317" id="f-26"> 2.125% Notes due 2030 </dei:Security12bTitle>
<dei:TradingSymbol contextRef="ia80236c4a4274bfa9aaa2a663c63be01_D20230317-20230317" id="f-27"> LLY30 </dei:TradingSymbol>
<dei:SecurityExchangeName contextRef="ia80236c4a4274bfa9aaa2a663c63be01_D20230317-20230317" id="f-28"> NYSE </dei:SecurityExchangeName>
<dei:Security12bTitle contextRef="ibbd5c1346d1440fbad3d3b779ac7feda_D20230317-20230317" id="f-29"> 0.625% Notes due 2031 </dei:Security12bTitle>
<dei:TradingSymbol contextRef="ibbd5c1346d1440fbad3d3b779ac7feda_D20230317-20230317" id="f-30"> LLY31 </dei:TradingSymbol>
<dei:SecurityExchangeName contextRef="ibbd5c1346d1440fbad3d3b779ac7feda_D20230317-20230317" id="f-31"> NYSE </dei:SecurityExchangeName>
<dei:Security12bTitle contextRef="ic2fbce5421e84b72b5ca953903f1a50b_D20230317-20230317" id="f-32"> 0.500% Notes due 2033 </dei:Security12bTitle>
<dei:TradingSymbol contextRef="ic2fbce5421e84b72b5ca953903f1a50b_D20230317-20230317" id="f-33"> LLY33 </dei:TradingSymbol>
<dei:SecurityExchangeName contextRef="ic2fbce5421e84b72b5ca953903f1a50b_D20230317-20230317" id="f-34"> NYSE </dei:SecurityExchangeName>
<dei:Security12bTitle contextRef="if1e319d2317a4561a5dff80511807f9f_D20230317-20230317" id="f-35"> 6.77% Notes due 2036 </dei:Security12bTitle>
<dei:TradingSymbol contextRef="if1e319d2317a4561a5dff80511807f9f_D20230317-20230317" id="f-36"> LLY36 </dei:TradingSymbol>
<dei:SecurityExchangeName contextRef="if1e319d2317a4561a5dff80511807f9f_D20230317-20230317" id="f-37"> NYSE </dei:SecurityExchangeName>
<dei:Security12bTitle contextRef="i2c5a13aca2324fe48e9a35d33e2f999e_D20230317-20230317" id="f-38"> 1.625% Notes due 2043 </dei:Security12bTitle>
<dei:TradingSymbol contextRef="i2c5a13aca2324fe48e9a35d33e2f999e_D20230317-20230317" id="f-39"> LLY43 </dei:TradingSymbol>
<dei:SecurityExchangeName contextRef="i2c5a13aca2324fe48e9a35d33e2f999e_D20230317-20230317" id="f-40"> NYSE </dei:SecurityExchangeName>
<dei:Security12bTitle contextRef="i6d19e4b8bdf047978a1b6f8bf80515c8_D20230317-20230317" id="f-41"> 1.700% Notes due 2049 </dei:Security12bTitle>
<dei:TradingSymbol contextRef="i6d19e4b8bdf047978a1b6f8bf80515c8_D20230317-20230317" id="f-42"> LLY49A </dei:TradingSymbol>
<dei:SecurityExchangeName contextRef="i6d19e4b8bdf047978a1b6f8bf80515c8_D20230317-20230317" id="f-43"> NYSE </dei:SecurityExchangeName>
<dei:Security12bTitle contextRef="idc48241e1e47492f8216126fab19a77a_D20230317-20230317" id="f-44"> 1.125% Notes due 2051 </dei:Security12bTitle>
<dei:TradingSymbol contextRef="idc48241e1e47492f8216126fab19a77a_D20230317-20230317" id="f-45"> LLY51 </dei:TradingSymbol>
<dei:SecurityExchangeName contextRef="idc48241e1e47492f8216126fab19a77a_D20230317-20230317" id="f-46"> NYSE </dei:SecurityExchangeName>
<dei:Security12bTitle contextRef="id04ee066e89940ed95215795392babff_D20230317-20230317" id="f-47"> 1.375% Notes due 2061 </dei:Security12bTitle>
<dei:TradingSymbol contextRef="id04ee066e89940ed95215795392babff_D20230317-20230317" id="f-48"> LLY61 </dei:TradingSymbol>
<dei:SecurityExchangeName contextRef="id04ee066e89940ed95215795392babff_D20230317-20230317" id="f-49"> NYSE </dei:SecurityExchangeName>
<dei:EntityEmergingGrowthCompany contextRef="i55b5a9349f3c4011865eeedb73223072_D20230317-20230317" id="f-50"> false </dei:EntityEmergingGrowthCompany>
</xbrl>

2 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 2/08/24  Eli Lilly & Co.                   424B2                  2:582K                                   Donnelley … Solutions/FA
 2/07/24  Eli Lilly & Co.                   424B2                  1:523K                                   Donnelley … Solutions/FA
↑Top
Filing Submission 0000059478-23-000118   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)
Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
About — Privacy — Redactions — Help — Mon., Apr. 29, 7:38:26.1pm ET